Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Are Moderna’s Coronavirus Gains Over?


Moderna (NASDAQ: MRNA) shares skyrocketed 309% this year to a record high on May 18 as investors bet on the company's investigational coronavirus vaccine. But sentiment hasn't been so great in recent days, and the stock dropped 35% from that high.

Image source: Getty Images.

What has investors worried? A few recent headlines.

Continue reading


Source Fool.com

Like: 0
Share

Comments